Marginal Revolution has a post by Alex Tabborok on pharmaceuticals, linking to a recent New Yorker piece by Malcolm Gladwell.

One key point of both: U.S. prices are actually lower than prices in other nations for drugs that are off-patent because competition from generics keeps the price down. Few who favor re-importation would be willing to give up this part of our system.

posted by James DeLong @ 3:30 PM | General

Link to this Entry | Printer-Friendly | Email a Comment | Post a Comment(0)